STING1 and neoplasm: However, due to the immunosuppressive TME and problems such as tumor immune escape by immune checkpoint blockade (ICB) and adoptive cell transfer (ACT) [285], the activation of the cGAS–STING pathway by RT remains transient and suboptimal, and it is unable to maintain strong antitumor immunity.